IVC Wealth Advisors LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 4.2% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,566 shares of the healthcare conglomerate’s stock after selling 69 shares during the period. IVC Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $820,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Western Pacific Wealth Management LP increased its stake in UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock worth $456,000 after purchasing an additional 19 shares during the period. Richwood Investment Advisors LLC increased its stake in UnitedHealth Group by 0.4% during the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate’s stock worth $2,654,000 after buying an additional 20 shares during the period. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares during the period. Prentice Wealth Management LLC increased its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,527 shares of the healthcare conglomerate’s stock worth $1,278,000 after acquiring an additional 21 shares during the period. Finally, 44 Wealth Management LLC grew its stake in UnitedHealth Group by 1.6% during the 4th quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock worth $662,000 after purchasing an additional 21 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Trading Up 1.0%
NYSE UNH opened at $301.08 on Friday. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a market cap of $273.12 billion, a PE ratio of 19.42, a P/E/G ratio of 1.37 and a beta of 0.56. The firm’s fifty day moving average is $430.87 and its two-hundred day moving average is $494.23. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
Insider Buying and Selling at UnitedHealth Group
In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the company’s stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction on Wednesday, May 14th. The stock was acquired at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now directly owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders have bought 109,408 shares of company stock valued at $31,607,768. 0.33% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on UNH shares. Royal Bank of Canada decreased their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. Wall Street Zen cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $677.00 to $351.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. TD Cowen lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 target price on the stock. in a report on Monday, May 19th. Finally, KeyCorp lowered their price objective on UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $441.87.
Get Our Latest Stock Report on UnitedHealth Group
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- Technology Stocks Explained: Here’s What to Know About Tech
- AXON: Competition Intensifies as Motorola Makes $4.4B Acquisition
- Insider Buying Explained: What Investors Need to Know
- MarketBeat Week in Review – 05/26 – 05/30
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Nike’s Amazon Expansion Could Signal a Turnaround in 2025
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.